All Biomarkers

    Omega-3 Index (RBC EPA+DHA)

    Cardiovascular
    Fatty Acid Status
    %

    The Omega-3 Index expresses the combined EPA+DHA content of red blood cell membranes as a percentage of total fatty acids. Because membrane composition turns over slowly, it is a robust marker of habitual omega-3 status that is less affected by a single recent meal than plasma measures.

    What It Measures

    The percentage of eicosapentaenoic acid (EPA) plus docosahexaenoic acid (DHA) in red blood cell membrane fatty acids — a stable, validated measure of long-term tissue omega-3 status reflecting intake over the ~120-day red-cell lifespan rather than a transient snapshot.

    Optimal vs. Lab Range

    Longevity Optimal
    ≥8% (target 8–12%)

    Target range for optimal health and longevity based on research.

    Standard Lab
    Conventional labs often report 4–8% as 'intermediate'; there is no single universal reference range

    Population-based reference range from standard labs.

    Why It Matters

    Higher long-chain omega-3 status is consistently associated with lower cardiovascular and all-cause mortality. A pooled analysis of 17 prospective cohorts found individuals in the highest versus lowest quintile of circulating EPA+DHA had roughly a 15–20% lower risk of all-cause mortality, and low membrane omega-3 (Omega-3 Index <4%) marks substantially higher risk of cardiovascular events and sudden cardiac death, while ≥8% is associated with greater cardioprotection. Omega-3 status also relates to inflammatory tone, triglycerides and healthy red-cell indices, making it a useful, modifiable longevity marker.

    When Low

    Omega-3 Index <4%: low membrane omega-3 status, associated with higher cardiovascular and sudden-cardiac-death risk.

    When Optimal

    8–12%: robust omega-3 status associated with greater cardiovascular protection.

    When High

    Very high levels are generally well tolerated; discuss bleeding risk and context (e.g., around surgery or anticoagulation) with your physician.

    How to Optimize

    The Omega-3 Index is highly responsive to intake. Regular consumption of oily fish (salmon, sardines, mackerel, herring) and, where appropriate, EPA/DHA supplementation raises the index over 8–12 weeks; retest after ~3–4 months to confirm response. Requirements vary between individuals, so dosing is individualized with your physician. This content is educational and not a substitute for medical advice.

    Key Interventions & Linked Compounds

    Strong evidence

    Key Interventions

    Oily fish intake
    EPA/DHA supplementation

    Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

    Ordering Notes

    Specimen

    Dried blood spot (fatty acid panel)

    Patient prep

    No fasting required. Maintain usual diet and medications unless advised.

    Recommended cadence

    Every 6–12 months (retest ~3–4 months after changing intake)

    Reporting unit

    %

    Pre-analytic notes

    Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

    Available panels

    Dried blood spot (fatty acid panel)
    Whole blood / RBC fatty acid analysis

    Recommended Follow-Up Actions

    1. 1

      Confirm the result is reliable

      Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Omega-3 Index (RBC EPA+DHA).

    2. 2

      Compare against optimal, not just lab range

      Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.

    3. 3

      Pair with related markers

      Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.

    4. 4

      Discuss interventions with a clinician

      Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.

    5. 5

      Re-test on a defined cadence

      If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.

    Testing Information

    Recommended Frequency

    Every 6–12 months (retest ~3–4 months after changing intake)

    Fasting Requirement

    No fasting required

    Available Test Types

    Dried blood spot (fatty acid panel)
    Whole blood / RBC fatty acid analysis
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation